Consequently, we have compiled an overview of the regulatory mechanisms involving NFATc1 in bone destruction and endeavored to identify potential bioactive compounds that could modulate NFATc1, thus providing valuable insights for the treatment of RA-related bone damage. The gene discussed is NFATC1; the disease is rheumatoid arthritis.